Apr'05 | Apr'06 | Apr'07 | Apr'08 | Apr'09 | Apr'10 | Apr'11 | Apr'12 | Apr'13 | Apr'14 | Apr'15 | Apr'16 | Apr'17 | Apr'18 | Apr'19 | Apr'20 | Apr'21 | Apr'22 | Apr'23 | Apr'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $10.1B | $11.3B | $12.3B | $13.5B | $14.6B | $15.8B | $15.9B | $16.2B | $16.6B | $17.0B | $20.3B | $28.8B | $29.7B | $30.0B | $30.6B | $28.9B | $30.1B | $31.7B | $31.2B | $32.4B |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Medtronic plc's last 12-month Revenue is $33.0B, based on the financial report for Oct 25, 2024 (Q4 2024).
Over the last year, Medtronic plc's Revenue growth was 3.3%. The average annual Revenue growth rates for Medtronic plc have been 3.1% over the past three years, 1.3% over the past five years.
Over the last year, Medtronic plc's Revenue growth was 3.3%, which is higher than industry growth of 0.1%. It indicates that Medtronic plc's Revenue growth is Good.